Table 2. Multivariate analysis for mortality.
| Variables | 14-day mortality | 30-day mortality | ||||
|---|---|---|---|---|---|---|
| p-value | OR | 95%CI | p-value | OR | 95%CI | |
| Immunosuppression | 0.311 | – | – | 0.075 | – | – |
| SOFA score (1 point increase at the diagnosis of infection) | 0.537 | – | – | 0.010 * | 1.497 | 1.103–2.032 |
| APACHE-II score (at the diagnosis of infection) | 0.181 | – | – | 0.985 | – | – |
| CVVHF treatment | 0.017 * | 6.409 | 1.395–29.433 | |||
| Age | 0.372 | – | – | |||
| Hypertension | 0.083 | – | – | |||
| Malignancy | 0.776 | – | – | |||
| Hypokalemia | 0.048 * | 5.651 | 1.019–31.330 | |||
Nagelkerke R2: 0.498 (14-day mortality); Nagelkerke R2: 0.497 (30-day mortality).
*
p<0.05. Bold values were used for mentioning only the statistically significant results.